RECORDGATE: unlocking the power of medication records to enable every aspect of digital health & care to be joined-up

处方药是医疗保健中最常见的干预措施;在英国，它是NHS支出的第二高领域，仅次于员工成本（PSNC，2021）。在政府政策和资金的支持下，通过虚拟病房，数字化社会护理，健康老龄化挑战等举措，数字化转型和创新在医疗保健领域已经司空见惯。然而，药物是这种数字化的一个重要部分，但目前还没有。例如，远程患者监护平台将自己定位为远程管理患者的“完整”平台，与100多个第三方设备集成，但不包括药物数据。福尔斯预防是另一个使用数据作为预测工具的增长空间--这里也不包括药物数据，尽管药物是福尔斯的主要指标。其他这样的例子存在于护理规划空间，长期状况管理和专科护理，例如癌症。出现这种差距是因为目前这些平台没有以他们可以轻松使用和从中获得见解的格式提供的正确数据，因此，依赖于患者手动输入他们的药物信息-数据，这些数据通常是缺失的，不完整或不准确的，这个以需求为导向的工业研究项目将以协作方式工作，设计，开发和测试一种新颖的，改变游戏规则的可互操作的药物洞察管道和数据解决方案，以满足这一未满足的市场需求-提供前所未有的洞察力/智能，可用于预先解决药物相关问题_特定于患者_。以真正可扩展的方式，它将允许为英国任何拥有NHS号码的患者提供丰富和情境化的药物见解，从而打开巨大的市场机会。该项目将把药物置于正在进行的卫生和护理数字化转型的核心，关闭护理人员，临床医生和患者之间的循环。

Prescribed medicines are the most common intervention in healthcare; in the UK, it is the second highest area of NHS spending, after staff costs (PSNC, 2021).Digital transformation and innovation have become commonplace in health and care, backed by government policy and funding, through initiatives such as Virtual Wards, Digitising Social Care, Healthy Ageing Challenge, among others. However, medicines are an essential but currently absent part of this digitisation. For example, remote patient monitoring platforms position themselves as 'complete' platforms to manage patients remotely, integrating with over 100+ third-party devices -- medicines data, however, is not included. Falls prevention is another growing space using data as as a predictive tool -- here too, medicines data, is not included despite medicines being a leading indicator for falls. Other such examples exist in the care planning space, long-term condition management, and specialist care e.g. cancer.This gap has arisen because currently these platforms do not have the right data available in a format that they can easily use and draw insights from and are, therefore, reliant on patients manually inputting their information about their medicines -- data, which is often missing, incomplete or inaccurate, reducing its usefulness.Working in a collaborative approach, this demand-led industrial research project will design, develop, and test a novel, game-changing interoperable medicines insights pipeline and data solution to address this unmet market need -- delivering unprecedented insights/intelligence that can be used to pre-empt medicines-related issues _specific to the patient_.**In a truly scalable manner, it will allow rich and contextualised medicines insights to be provided for any patient in the UK with an NHS number, opening up a huge market opportunity.**This project will place medicines at the heart of the ongoing digital transformation of health and care, closing the loop between carers, clinicians, and their patients.